|drug2958||Transfusion of SARS-CoV-2 Convalescent Plasma. Wiki||1.00|
|drug2959||Transfusion of standard Plasma. Wiki||1.00|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This is a randomized, double-blind, placebo-controlled, multicenter, 28-day study of adult participants hospitalized with COVID-19, with a safety follow-up telephone call at Day 60.
Description: Respiratory improvement is defined as sustained peripheral oxygen saturation (SpO2) ≥94% on room air.Measure: Time from Randomization to Respiratory Improvement Time: up to Day 28